Professor Peter Sleight's reflections on the use of beta-blocking agents after myocardial infarction.
Sleight
P
P
University of Oxford, John Radcliffe Hospital, United Kingdom.
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000209:etiology; D000075202:Contraindications; D006801:Humans; D007262:Infusions, Intravenous; D015201:Meta-Analysis as Topic; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D012008:Recurrence
D000319:Adrenergic beta-Antagonists